{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:39:18Z","timestamp":1792179558417,"version":"4.4.0"},"reference-count":233,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"VA Merit Review"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although endocrinologists specialize in the management of hormones, they often lack sufficient training in the appropriate use of the diverse array of available contraceptive options. All medical providers should possess a fundamental understanding of contraceptive methods for pregnancy prevention, but endocrinologists should have a deeper understanding of birth control possibilities due to the useful role of hormone-containing contraception in managing endocrine and metabolic disorders. This manuscript outlines the history of contraception and then evaluates both existing and emerging birth control options for women and men. Delving further, this review also explores the impact of individual sex steroids\u2014estrogens, progestins, and androgens\u2014used in hormonal contraceptive methods. In addition to their role as contraceptives, the influence of these exogenous hormones on the hypothalamic-pituitary-gonadal axis warrants careful consideration. These effects extend beyond pregnancy prevention and can be instrumental in regularizing menses, sex steroid replacement, and androgen suppression. Finally, this review provides tailored suggestions for contraceptive usage in patients with endocrine disorders, ensuring comprehensive care and informed decision-making in clinical practice.<\/jats:p>","DOI":"10.1210\/endrev\/bnaf016","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T09:37:45Z","timestamp":1747993065000},"page":"736-759","source":"Crossref","is-referenced-by-count":7,"title":["Contraceptive Selection for the Endocrine Patient: What an Endocrinologist Should Know"],"prefix":"10.1210","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6884-7748","authenticated-orcid":false,"given":"Adnin","family":"Zaman","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Rochester Medical Center , Rochester, NY 14642 ,","place":["USA"]},{"name":"Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Center , Aurora, CO 80045 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0208-8432","authenticated-orcid":false,"given":"Aaron","family":"Lazorwitz","sequence":"additional","affiliation":[{"name":"Division of Complex Family Planning, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University , New Haven, CT 06510 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7634-1093","authenticated-orcid":false,"given":"Margaret E","family":"Wierman","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Center , Aurora, CO 80045 ,","place":["USA"]},{"name":"Division of Endocrinology and Research Service, Rocky Mountain Regional Veterans Administration , Aurora, CO 80045 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"2025091917040850600_bnaf016-B1","author":"Guttmacher Institute","year":"2024"},{"key":"2025091917040850600_bnaf016-B2","author":"United Nations Department of Economic and Social Affairs, Population Division","year":"2022"},{"issue":"179","key":"2025091917040850600_bnaf016-B3","first-page":"1","article-title":"Fertility of men and women aged 15\u201349 in the United States: national survey of family growth 2015\u20132019","author":"Martinez","year":"2023","journal-title":"Natl Health Stat Report"},{"issue":"3","key":"2025091917040850600_bnaf016-B4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41574-021-00598-8","article-title":"Environmental factors in declining human fertility","volume":"18","author":"Skakkebaek","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"2025091917040850600_bnaf016-B5","doi-asserted-by":"crossref","first-page":"e112236","DOI":"10.1371\/journal.pone.0112236","article-title":"Variation in male reproductive longevity across traditional societies","volume":"9","author":"Vinicius","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"2025091917040850600_bnaf016-B6","doi-asserted-by":"crossref","first-page":"hoac005","DOI":"10.1093\/hropen\/hoac005","article-title":"Women's reproductive span: a systematic scoping review","volume":"2022","author":"Nabhan","year":"2022","journal-title":"Hum Reprod Open"},{"issue":"6641","key":"2025091917040850600_bnaf016-B7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1126\/science.adf9341","article-title":"A brief history and future prospects of contraception","volume":"380","author":"Anderson","year":"2023","journal-title":"Science"},{"key":"2025091917040850600_bnaf016-B8","author":"Lay"},{"issue":"4","key":"2025091917040850600_bnaf016-B9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/014107689308600415","article-title":"The history of the condom","volume":"86","author":"Youssef","year":"1993","journal-title":"J R Soc Med"},{"issue":"4","key":"2025091917040850600_bnaf016-B10","first-page":"216","article-title":"The cervical cap. An alternate barrier contraceptive method","volume":"79","author":"Gilbirds","year":"1982","journal-title":"Mo Med"},{"key":"2025091917040850600_bnaf016-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.urology.2023.09.012","article-title":"Historical review of the vasectomy: antiquated beliefs, novel techniques, and contemporary challenges","volume":"182","author":"Drobner","year":"2023","journal-title":"Urology"},{"key":"2025091917040850600_bnaf016-B12","doi-asserted-by":"crossref","first-page":"114581","DOI":"10.1016\/j.addr.2022.114581","article-title":"Long-acting intrauterine systems: recent advances, current challenges, and future opportunities","volume":"191","author":"Fanse","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"2025091917040850600_bnaf016-B13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/gyn.2021.0101","article-title":"The history of female surgical sterilization","volume":"37","author":"Whittum","year":"2021","journal-title":"J Gynecol Surg"},{"issue":"2","key":"2025091917040850600_bnaf016-B14","doi-asserted-by":"crossref","first-page":"e2147343","DOI":"10.1001\/jamanetworkopen.2021.47343","article-title":"Outcomes from opportunistic salpingectomy for ovarian cancer prevention","volume":"5","author":"Hanley","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4146","key":"2025091917040850600_bnaf016-B15","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/163596a0","article-title":"Oscar Hertwig (1849\u20131922)","volume":"163","year":"1949","journal-title":"Nature"},{"issue":"2","key":"2025091917040850600_bnaf016-B16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jhmas\/57.2.117","article-title":"Women's trials: the approval of the first oral contraceptive pill in the United States and Great Britain","volume":"57","author":"Junod","year":"2002","journal-title":"J Hist Med Allied Sci"},{"issue":"3\/4","key":"2025091917040850600_bnaf016-B17","first-page":"75","article-title":"General overview of natural family planning","volume":"54","author":"P\u00e9rez","year":"1998","journal-title":"Genus"},{"key":"2025091917040850600_bnaf016-B18","volume-title":"The Rhythm of Sterility and Fertility in Women","author":"Latz","year":"1939"},{"issue":"1","key":"2025091917040850600_bnaf016-B19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2307\/2135230","article-title":"Was Margaret Sanger a racist?","volume":"17","author":"Valenza","year":"1985","journal-title":"Fam Plann Perspect"},{"issue":"5","key":"2025091917040850600_bnaf016-B20","first-page":"165","article-title":"Estrogens in oral contraceptives: historical perspectives","volume":"150","author":"Goldzieher","year":"1982","journal-title":"Johns Hopkins Med J"},{"issue":"3","key":"2025091917040850600_bnaf016-B21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1353\/pbm.1993.0066","article-title":"The history of steroidal contraceptive development: the estrogens","volume":"36","author":"Goldzieher","year":"1993","journal-title":"Perspect Biol Med"},{"key":"2025091917040850600_bnaf016-B22","year":"2015"},{"issue":"5","key":"2025091917040850600_bnaf016-B23","first-page":"662","article-title":"History of intrauterine devices","volume":"51","author":"Margulies","year":"1975","journal-title":"Bull N Y Acad Med"},{"issue":"2","key":"2025091917040850600_bnaf016-B24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jhmas\/jrab004","article-title":"The comeback of the IUD in twenty-first century USA","volume":"76","author":"Watkins","year":"2021","journal-title":"J Hist Med Allied Sci"},{"issue":"16","key":"2025091917040850600_bnaf016-B25","doi-asserted-by":"crossref","first-page":"996","DOI":"10.4236\/ojog.2014.416140","article-title":"Long tail strings: impact of the Dalkon Shield 40 years later","volume":"4","author":"Roepke","year":"2014","journal-title":"Open J Obstet Gynecol"},{"key":"2025091917040850600_bnaf016-B26","volume-title":"The Copper T 380 Intrauterine Device: A Summary of Scientific Data.","author":"Sivin","year":"1992"},{"issue":"4","key":"2025091917040850600_bnaf016-B27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/GRF.0b013e318159c2f6","article-title":"The contraceptive implant","volume":"50","author":"Hohmann","year":"2007","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"2025091917040850600_bnaf016-B28","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/aogs.14110","article-title":"Thirty years of mirena: a story of innovation and change in women's healthcare","volume":"100","author":"Gemzell-Danielsson","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"9","key":"2025091917040850600_bnaf016-B29","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1176\/appi.ajp.20230909","article-title":"Association between intrauterine system hormone dosage and depression risk","volume":"181","author":"Larsen","year":"2024","journal-title":"Am J Psychiatry"},{"issue":"6","key":"2025091917040850600_bnaf016-B30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/15622975.2022.2145354","article-title":"The potential association between psychiatric symptoms and the use of levonorgestrel intrauterine devices (LNG-IUDs): a systematic review","volume":"24","author":"Elsayed","year":"2023","journal-title":"World J Biol Psychiatry"},{"issue":"4","key":"2025091917040850600_bnaf016-B31","doi-asserted-by":"crossref","first-page":"450.e1","DOI":"10.1016\/j.ajog.2024.05.011","article-title":"Association of levonorgestrel-releasing intrauterine device with gynecologic and breast cancers: a national cohort study in Sweden","volume":"231","author":"Yi","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2025091917040850600_bnaf016-B32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.clbc.2021.03.013","article-title":"Meta-analysis of breast cancer risk in levonorgestrel-releasing intrauterine system users","volume":"21","author":"Silva","year":"2021","journal-title":"Clin Breast Cancer"},{"key":"2025091917040850600_bnaf016-B33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-3-030-46391-5_10","volume-title":"The Handbook of Contraception: Evidence Based Practice Recommendations and Rationales","author":"Natavio","year":"2020"},{"issue":"10","key":"2025091917040850600_bnaf016-B34","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/14740338.2017.1354985","article-title":"The safety of available and emerging options for emergency contraception","volume":"16","author":"Lee","year":"2017","journal-title":"Expert Opin Drug Saf"},{"issue":"5 Suppl","key":"2025091917040850600_bnaf016-B35","first-page":"S103","article-title":"Hormonal contraception: recent advances and controversies","volume":"90","author":"Practice Committee of American Society for Reproductive Medicine","year":"2008","journal-title":"Fertil Steril"},{"issue":"3","key":"2025091917040850600_bnaf016-B36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/GRF.0000000000000628","article-title":"Contraceptive technologies: looking ahead to new approaches to increase options for family planning","volume":"64","author":"Haddad","year":"2021","journal-title":"Clin Obstet Gynecol"},{"issue":"24","key":"2025091917040850600_bnaf016-B37","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1001\/jama.2021.21392","article-title":"Contraception selection, effectiveness, and adverse effects: a review","volume":"326","author":"Teal","year":"2021","journal-title":"JAMA"},{"key":"2025091917040850600_bnaf016-B38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bpobgyn.2020.03.004","article-title":"Overview of modern contraception","volume":"66","author":"Festin","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"2025091917040850600_bnaf016-B39","doi-asserted-by":"crossref","first-page":"2247093","DOI":"10.1080\/09513590.2023.2247093","article-title":"Hormonal and natural contraceptives: a review on efficacy and risks of different methods for an informed choice","volume":"39","author":"Genazzani","year":"2023","journal-title":"Gynecol Endocrinol"},{"key":"2025091917040850600_bnaf016-B40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/978-3-030-46391-5_12","volume-title":"The Handbook of Contraception: Evidence Based Practice Recommendations and Rationales","author":"Altshuler","year":"2020"},{"key":"2025091917040850600_bnaf016-B41","volume-title":"Contraceptive Technology","author":"Hatcher","year":"2018","edition":"21st ed"},{"issue":"2","key":"2025091917040850600_bnaf016-B42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nurpra.2012.06.010","article-title":"Knowledge and experiences of low-income patients with natural family planning","volume":"9","author":"Witt","year":"2013","journal-title":"J Nurse Pract"},{"issue":"2","key":"2025091917040850600_bnaf016-B43","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s10900-013-9777-7","article-title":"The role of health literacy and numeracy in contraceptive decision-making for urban Chicago women","volume":"39","author":"Yee","year":"2014","journal-title":"J Community Health"},{"issue":"5","key":"2025091917040850600_bnaf016-B44","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/humrep\/dem003","article-title":"The effectiveness of a fertility awareness based method to avoid pregnancy in relation to a couple's sexual behaviour during the fertile time: a prospective longitudinal study","volume":"22","author":"Frank-Herrmann","year":"2007","journal-title":"Human Reproduction"},{"key":"2025091917040850600_bnaf016-B45","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bpobgyn.2019.12.003","article-title":"Fertility awareness-based methods of family planning","volume":"66","author":"Simmons","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"2025091917040850600_bnaf016-B46","first-page":"123","article-title":"Determination of luteal phase length by quantitative basal temperature methods: validation against the midcycle LH peak","volume":"13","author":"Prior","year":"1990","journal-title":"Clin Invest Med"},{"issue":"2","key":"2025091917040850600_bnaf016-B47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/bmjsrh-2019-200488","article-title":"Use of menstruation and fertility app trackers: a scoping review of the evidence","volume":"47","author":"Earle","year":"2021","journal-title":"BMJ Sex Reprod Health"},{"issue":"4","key":"2025091917040850600_bnaf016-B48","doi-asserted-by":"crossref","first-page":"e13404","DOI":"10.2196\/13404","article-title":"Wearable sensors reveal menses-driven changes in physiology and enable prediction of the fertile window: observational study","volume":"21","author":"Goodale","year":"2019","journal-title":"J Med Internet Res"},{"key":"2025091917040850600_bnaf016-B49","doi-asserted-by":"crossref","first-page":"103290","DOI":"10.1016\/j.jtherbio.2022.103290","article-title":"The use of wearable devices for predicting biphasic basal body temperature to estimate the date of ovulation in women","volume":"108","author":"Uchida","year":"2022","journal-title":"J Therm Biol"},{"issue":"3","key":"2025091917040850600_bnaf016-B50","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1136\/bmjsrh-2020-200632","article-title":"New types of diaphragms and cervical caps versus older types of diaphragms and different gels for contraception: a systematic review","volume":"47","author":"Lindh","year":"2020","journal-title":"BMJ Sex Reprod Health"},{"key":"2025091917040850600_bnaf016-B51","doi-asserted-by":"crossref","first-page":"100031","DOI":"10.1016\/j.conx.2020.100031","article-title":"A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial","volume":"2","author":"Thomas","year":"2020","journal-title":"Contracept X"},{"key":"2025091917040850600_bnaf016-B52","author":"Guttmacher Institute","year":"2020"},{"issue":"3","key":"2025091917040850600_bnaf016-B53","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.contraception.2013.11.011","article-title":"Worldwide use of intrauterine contraception: a review","volume":"89","author":"Buhling","year":"2014","journal-title":"Contraception"},{"issue":"7-8","key":"2025091917040850600_bnaf016-B54","doi-asserted-by":"crossref","first-page":"E274","DOI":"10.5489\/cuaj.4017","article-title":"CUA guideline: vasectomy","volume":"10","author":"Zini","year":"2016","journal-title":"Can Urol Assoc J"},{"key":"2025091917040850600_bnaf016-B55","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-3-319-40788-3_8","volume-title":"Immune Infertility: Impact of Immune Reactions on Human Fertility","author":"Marconi","year":"2017"},{"issue":"15","key":"2025091917040850600_bnaf016-B56","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1056\/NEJMp1510514","article-title":"Revisiting essure--toward safe and effective sterilization","volume":"373","author":"Dhruva","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"2025091917040850600_bnaf016-B57","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ajog.2021.12.261","article-title":"Female permanent contraception trends and updates","volume":"226","author":"Fang","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"2025091917040850600_bnaf016-B58","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/OAJC.S385255","article-title":"Efficacy of tubal surgery for permanent contraception: considerations for the clinician","volume":"14","author":"Tasset","year":"2023","journal-title":"Open Access J Contracept"},{"issue":"3","key":"2025091917040850600_bnaf016-B59","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ajog.2020.09.011","article-title":"Salpingectomy vs tubal ligation for sterilization: a systematic review and meta-analysis","volume":"224","author":"Mills","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"2025091917040850600_bnaf016-B60","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jamasurg.2023.4164","article-title":"Salpingectomy for the primary prevention of ovarian cancer: a systematic review","volume":"158","author":"Kahn","year":"2023","journal-title":"JAMA Surg"},{"issue":"2","key":"2025091917040850600_bnaf016-B61","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/2229-516X.136781","article-title":"Female sterilization failure: review over a decade and its clinicopathological correlation","volume":"4","author":"Date","year":"2014","journal-title":"Int J Appl Basic Med Res"},{"key":"2025091917040850600_bnaf016-B62","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejogrb.2023.10.017","article-title":"Microsurgical anastomosis of the fallopian tubes after tubal ligation: a systematic review and meta-analysis","volume":"291","author":"Sastre","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"2025091917040850600_bnaf016-B63","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.rbmo.2020.01.003","article-title":"Systematic review of pregnancy outcomes after fertility-preserving treatment of uterine fibroids","volume":"40","author":"Khaw","year":"2020","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"2025091917040850600_bnaf016-B64","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/aogs.14002","article-title":"A study of pregnancy after endometrial ablation using linked population data","volume":"100","author":"Ibiebele","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2025091917040850600_bnaf016-B65","doi-asserted-by":"crossref","first-page":"100046","DOI":"10.1016\/j.jeud.2023.100046","article-title":"Pregnancy following ablation therapy: a literature review","volume":"4","author":"Heylen","year":"2023","journal-title":"J Endometr Uterine Disord"},{"issue":"8","key":"2025091917040850600_bnaf016-B66","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1007\/s00270-020-02521-6","article-title":"Pregnancy and its outcomes in patients after uterine fibroid embolization: a systematic review and meta-analysis","volume":"43","author":"Ghanaati","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"2025091917040850600_bnaf016-B67","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.contraception.2007.01.020","article-title":"Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action","volume":"75","author":"Ortiz","year":"2007","journal-title":"Contraception"},{"issue":"6","key":"2025091917040850600_bnaf016-B68","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.contraception.2016.08.011","article-title":"Use of intrauterine devices in nulliparous women","volume":"95","author":"Lohr","year":"2017","journal-title":"Contraception"},{"issue":"5","key":"2025091917040850600_bnaf016-B69","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/13625187.2018.1526898","article-title":"Safety of insertion of the copper IUD and LNG-IUS in nulliparous women: a systematic review","volume":"23","author":"Foran","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"2025091917040850600_bnaf016-B70","first-page":"687","article-title":"Synthesis and release of gonadotropins: effect of an oral contraceptive","volume":"62","author":"Dericks-Tan","year":"1983","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2025091917040850600_bnaf016-B71","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.contraception.2011.04.009","article-title":"Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide","volume":"84","author":"Endrikat","year":"2011","journal-title":"Contraception"},{"issue":"4","key":"2025091917040850600_bnaf016-B72","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/GRF.0000000000000072","article-title":"Progestins for contraception: modern delivery systems and novel formulations","volume":"57","author":"Royer","year":"2014","journal-title":"Clin Obstet Gynecol"},{"key":"2025091917040850600_bnaf016-B73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-030-52508-8_2","volume-title":"Progestogens in Obstetrics and Gynecology","author":"Schindler","year":"2021"},{"issue":"6","key":"2025091917040850600_bnaf016-B74","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/GCO.0000000000000819","article-title":"Progestins of today and tomorrow","volume":"34","author":"Liu","year":"2022","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"Suppl 1","key":"2025091917040850600_bnaf016-B75","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500148875","article-title":"Pharmacology of estrogens and progestogens: influence of different routes of administration","volume":"8","author":"Kuhl","year":"2005","journal-title":"Climacteric"},{"key":"2025091917040850600_bnaf016-B76","doi-asserted-by":"crossref","first-page":"101060","DOI":"10.1016\/j.yfrne.2023.101060","article-title":"Progesterone and contraceptive progestin actions on the brain: a systematic review of animal studies and comparison to human neuroimaging studies","volume":"69","author":"Pletzer","year":"2023","journal-title":"Front Neuroendocrinol"},{"issue":"3","key":"2025091917040850600_bnaf016-B77","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.contraception.2020.05.017","article-title":"Oral contraceptive generations\u2013time to stop using a marketing myth to define nomenclature","volume":"102","author":"Creinin","year":"2020","journal-title":"Contraception"},{"key":"2025091917040850600_bnaf016-B78","doi-asserted-by":"crossref","first-page":"107789","DOI":"10.1016\/j.pharmthera.2020.107789","article-title":"Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception","volume":"222","author":"Bick","year":"2021","journal-title":"Pharmacol Ther"},{"key":"2025091917040850600_bnaf016-B79","author":"Marques"},{"issue":"2","key":"2025091917040850600_bnaf016-B80","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tics.2016.11.005","article-title":"How oral contraceptives impact social-emotional behavior and brain function","volume":"21","author":"Montoya","year":"2017","journal-title":"Trends Cogn Sci"},{"issue":"1","key":"2025091917040850600_bnaf016-B81","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/emph\/eox009","article-title":"Oral contraceptives cause evolutionarily novel increases in hormone exposure: a risk factor for breast cancer","volume":"2017","author":"Lovett","year":"2017","journal-title":"Evol Med Public Health"},{"issue":"5","key":"2025091917040850600_bnaf016-B82","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1177\/0956797610368062","article-title":"Oral contraceptives suppress ovarian hormone production","volume":"21","author":"Fleischman","year":"2010","journal-title":"Psychol Sci"},{"issue":"1","key":"2025091917040850600_bnaf016-B83","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1701-2163(16)30692-2","article-title":"Ovarian follicular development during the use of oral contraception: a review","volume":"26","author":"Baerwald","year":"2004","journal-title":"J Obstet Gynaecol Can"},{"issue":"7","key":"2025091917040850600_bnaf016-B84","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/humrep\/16.7.1527","article-title":"Ovarian and endometrial function during hormonal contraception","volume":"16","author":"ESHRE Capri Workshop Group","year":"2001","journal-title":"Hum Reprod"},{"key":"2025091917040850600_bnaf016-B85","first-page":"473","article-title":"The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women","volume":"41","author":"Crowley","year":"1985","journal-title":"Recent Prog Horm Res"},{"issue":"6","key":"2025091917040850600_bnaf016-B86","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/13625187.2020.1815008","article-title":"Comparative pharmacokinetic analysis of levonorgestrel-releasing intrauterine systems and levonorgestrel-containing contraceptives with oral or subdermal administration route","volume":"25","author":"Hofmann","year":"2020","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"2025091917040850600_bnaf016-B87","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/0010-7824(94)90114-7","article-title":"Progestin-only oral contraception: a comprehensive review: II. Mode of action","volume":"50","author":"McCann","year":"1994","journal-title":"Contraception"},{"issue":"10","key":"2025091917040850600_bnaf016-B88","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1080\/17512433.2020.1821649","article-title":"Effects of progestin-only contraceptives on the endometrium","volume":"13","author":"Bastianelli","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2025091917040850600_bnaf016-B89","doi-asserted-by":"crossref","first-page":"109978","DOI":"10.1016\/j.contraception.2023.109978","article-title":"A commentary on progestin-only pills and the \u201cthree-hour window\u201d guidelines: timing of ingestion and mechanisms of action","volume":"122","author":"Wollum","year":"2023","journal-title":"Contraception"},{"issue":"2","key":"2025091917040850600_bnaf016-B90","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.contraception.2009.02.008","article-title":"Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons","volume":"80","author":"Hubacher","year":"2009","journal-title":"Contraception"},{"issue":"11","key":"2025091917040850600_bnaf016-B91","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","article-title":"Anti-M\u00fcllerian hormone and ovarian reserve: update on assessing ovarian function","volume":"105","author":"Moolhuijsen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025091917040850600_bnaf016-B92","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40834-018-0064-y","article-title":"Return of fertility after discontinuation of contraception: a systematic review and meta-analysis","volume":"3","author":"Girum","year":"2018","journal-title":"Contracept Reprod Med"},{"key":"2025091917040850600_bnaf016-B93","author":"Pfizer"},{"issue":"2","key":"2025091917040850600_bnaf016-B94","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0010-7824(74)90073-0","article-title":"The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review","volume":"10","author":"Schwallie","year":"1974","journal-title":"Contraception"},{"issue":"3","key":"2025091917040850600_bnaf016-B95","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/andr.12328","article-title":"Impact of various progestins with or without transdermal testosterone on gonadotropin levels for non-invasive hormonal male contraception: a randomized clinical trial","volume":"5","author":"Zitzmann","year":"2017","journal-title":"Andrology"},{"issue":"4","key":"2025091917040850600_bnaf016-B96","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/17512433.2020.1750365","article-title":"Estetrol (E4): the new estrogenic component of combined oral contraceptives","volume":"13","author":"Grandi","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"7","key":"2025091917040850600_bnaf016-B97","doi-asserted-by":"crossref","first-page":"e3008","DOI":"10.1210\/clinem\/dgac150","article-title":"Estradiol valerate vs ethinylestradiol in combined oral contraceptives: effects on the pituitary-ovarian axis","volume":"107","author":"Haverinen","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025091917040850600_bnaf016-B98","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00404-021-06380-5","article-title":"Endometrial hyperplasia as a risk factor of endometrial cancer","volume":"306","author":"Nees","year":"2022","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"2025091917040850600_bnaf016-B99","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/GCO.0000000000000751","article-title":"Oestrogen component of COCs: have we finally found a replacement for ethinyl estradiol?","volume":"33","author":"Voedisch","year":"2021","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"1","key":"2025091917040850600_bnaf016-B100","first-page":"3","article-title":"Estetrol as estrogen in a combined oral contraceptive, from the first in-human study to the contraceptive efficacy","volume":"3","author":"Mawet","year":"2021","journal-title":"Eur Gynecol Obstet"},{"issue":"7","key":"2025091917040850600_bnaf016-B101","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1517\/14656561003724713","article-title":"Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest","volume":"11","author":"Jensen","year":"2010","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"2025091917040850600_bnaf016-B102","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11154-011-9182-4","article-title":"Metabolic effects of contraceptive steroids","volume":"12","author":"Sitruk-Ware","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"key":"2025091917040850600_bnaf016-B103","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/OAJC.S61942","article-title":"Nomegestrol acetate\/17-beta estradiol: a review of efficacy, safety, and patient acceptability","volume":"6","author":"Akintomide","year":"2015","journal-title":"Open Access J Contracept"},{"issue":"1","key":"2025091917040850600_bnaf016-B104","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.contraception.2020.10.014","article-title":"Ethinyl estradiol vs estradiol valerate in combined oral contraceptives\u2014effect on glucose tolerance: a randomized, controlled clinical trial","volume":"103","author":"Haverinen","year":"2021","journal-title":"Contraception"},{"issue":"23","key":"2025091917040850600_bnaf016-B105","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.3390\/jcm10235625","article-title":"Estetrol: a new choice for contraception","volume":"10","author":"Fruzzetti","year":"2021","journal-title":"J Clin Med"},{"key":"2025091917040850600_bnaf016-B106","doi-asserted-by":"crossref","first-page":"110310","DOI":"10.1016\/j.contraception.2023.110310","article-title":"Comparison of estrogenic components used for hormonal contraception","volume":"130","author":"Stanczyk","year":"2023","journal-title":"Contraception"},{"issue":"3","key":"2025091917040850600_bnaf016-B107","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"van den Heuvel","year":"2005","journal-title":"Contraception"},{"issue":"4","key":"2025091917040850600_bnaf016-B108","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0010-7824(72)90068-6","article-title":"Reversible antifertility action of testosterone propionate in human males","volume":"5","author":"Reddy","year":"1972","journal-title":"Contraception"},{"issue":"4","key":"2025091917040850600_bnaf016-B109","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3181\/00379727-40-10527P","article-title":"Production of oligospermia in a man by the use of testosterone propionate","volume":"40","author":"Heckel","year":"1939","journal-title":"Proc Soc Exp Biol Med"},{"issue":"3","key":"2025091917040850600_bnaf016-B110","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1210\/jc.2008-1902","article-title":"The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men","volume":"94","author":"Brambilla","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025091917040850600_bnaf016-B111","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-med-042418-010947","article-title":"Male hormonal contraception","volume":"71","author":"Thirumalai","year":"2020","journal-title":"Annu Rev Med"},{"issue":"5","key":"2025091917040850600_bnaf016-B112","first-page":"521","article-title":"Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations","volume":"19","author":"Seminara","year":"1998","journal-title":"Endocr Rev"},{"issue":"23","key":"2025091917040850600_bnaf016-B113","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJM198612043152306","article-title":"Gonadotropin-releasing hormone: role of pulsatile secretion in the regulation of reproduction","volume":"315","author":"Marshall","year":"1986","journal-title":"N Engl J Med"},{"issue":"2","key":"2025091917040850600_bnaf016-B114","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1210\/endo-109-2-376","article-title":"Frequency and amplitude of gonadotropin-releasing hormone stimulation and gonadotropin secretion in the rhesus monkey","volume":"109","author":"Wildt","year":"1981","journal-title":"Endocrinology"},{"issue":"4","key":"2025091917040850600_bnaf016-B115","first-page":"603","article-title":"Male contraception","volume":"93","author":"Abbe","year":"2020","journal-title":"Yale J Biol Med"},{"issue":"2","key":"2025091917040850600_bnaf016-B116","first-page":"83","article-title":"Use of contraception among reproductive-aged women in the United States, 2014 and 2016","volume":"1","author":"Kavanaugh","year":"2020","journal-title":"F S Rep"},{"key":"2025091917040850600_bnaf016-B117","author":"Daniels","year":"2020"},{"key":"2025091917040850600_bnaf016-B118","author":"United Nations Department of Economic and Social Affairs, Population Division","year":"2022"},{"issue":"11","key":"2025091917040850600_bnaf016-B119","first-page":"CD003553","article-title":"Triphasic versus monophasic oral contraceptives for contraception","volume":"2011","author":"Van Vliet","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2025091917040850600_bnaf016-B120","first-page":"CD002032","article-title":"Biphasic versus monophasic oral contraceptives for contraception","volume":"2006","author":"Van Vliet","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"2025091917040850600_bnaf016-B121","first-page":"CD009038","article-title":"Quadriphasic versus monophasic oral contraceptives for contraception","volume":"2011","author":"Van Vliet","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2025091917040850600_bnaf016-B122","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/biolre\/ioad154","article-title":"Reversible female contraceptives: historical, current, and future perspectives","volume":"110","author":"Barton","year":"2024","journal-title":"Biol Reprod"},{"issue":"1","key":"2025091917040850600_bnaf016-B123","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0015-0282(99)00205-8","article-title":"Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 \u03bcg) and ethinyl estradiol (15 \u03bcg) on ovarian activity","volume":"72","author":"Sullivan","year":"1999","journal-title":"Fertil Steril"},{"issue":"5","key":"2025091917040850600_bnaf016-B124","first-page":"905","article-title":"Evaluation of extended and continuous use oral contraceptives","volume":"4","author":"Wright","year":"2008","journal-title":"Ther Clin Risk Manag"},{"issue":"7","key":"2025091917040850600_bnaf016-B125","first-page":"CD004695","article-title":"Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception","volume":"2014","author":"Edelman","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2025091917040850600_bnaf016-B126","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1158\/0008-5472.CAN-20-2476","article-title":"Time-dependent effects of oral contraceptive use on breast, ovarian, and endometrial cancers","volume":"81","author":"Karlsson","year":"2021","journal-title":"Cancer Res"},{"issue":"26","key":"2025091917040850600_bnaf016-B127","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","article-title":"Oral contraceptives and the risk of breast cancer","volume":"346","author":"Marchbanks","year":"2002","journal-title":"N Engl J Med"},{"key":"2025091917040850600_bnaf016-B128","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fendo.2020.00603","article-title":"Hormonal contraception and bone health in adolescents","volume":"11","author":"Bachrach","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025091917040850600_bnaf016-B129","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/978-3-030-70932-7_21","volume-title":"Female and Male Contraception","author":"Birkhaeuser","year":"2021"},{"issue":"4","key":"2025091917040850600_bnaf016-B130","first-page":"CD003552","article-title":"Skin patch and vaginal ring versus combined oral contraceptives for contraception","volume":"2013","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"2025091917040850600_bnaf016-B131","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1080\/17512433.2017.1356718","article-title":"Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis","volume":"10","author":"Farris","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2025091917040850600_bnaf016-B132","author":"World Health Organization","year":"2015"},{"key":"2025091917040850600_bnaf016-B133","first-page":"1","article-title":"U.S. Medical Eligibility Criteria for Contraceptive Use, 2016","author":"Curtis","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"2025091917040850600_bnaf016-B134","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AOG.0b013e31828317cc","article-title":"Contraceptive failures in overweight and obese combined hormonal contraceptive users","volume":"121","author":"McNicholas","year":"2013","journal-title":"Obstet Gynecol"},{"key":"2025091917040850600_bnaf016-B135","author":"Corium International, Inc"},{"issue":"2","key":"2025091917040850600_bnaf016-B136","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.contraception.2016.10.010","article-title":"Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systematic review","volume":"95","author":"Dragoman","year":"2017","journal-title":"Contraception"},{"issue":"6","key":"2025091917040850600_bnaf016-B137","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/ehf2.14104","article-title":"Obesity and contraceptive use: impact on cardiovascular risk","volume":"9","author":"Rosano","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"6","key":"2025091917040850600_bnaf016-B138","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1097\/AOG.0000000000003332","article-title":"ACOG practice bulletin no. 206: use of hormonal contraception in women with coexisting medical conditions: correction","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"2025091917040850600_bnaf016-B139","volume-title":"StatPearls [Internet]","author":"Cooper","year":"2024  29"},{"issue":"2","key":"2025091917040850600_bnaf016-B140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/17512433.2021.1878876","article-title":"The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism","volume":"14","author":"Grandi","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"2025091917040850600_bnaf016-B141","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.contraception.2015.09.015","article-title":"Clotting factor changes during the first cycle of oral contraceptive use","volume":"93","author":"Westhoff","year":"2016","journal-title":"Contraception"},{"issue":"3","key":"2025091917040850600_bnaf016-B142","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0014-2999(02)02337-3","article-title":"Norethisterone is bioconverted to oestrogenic compounds that activate both the oestrogen receptor \u03b1 and oestrogen receptor \u03b2 in vitro","volume":"452","author":"Pasapera","year":"2002","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"2025091917040850600_bnaf016-B143","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/AOG.0000000000004896","article-title":"Association of progestogens and venous thromboembolism among women of reproductive age","volume":"140","author":"Cockrum","year":"2022","journal-title":"Obstet Gynecol"},{"key":"2025091917040850600_bnaf016-B144","doi-asserted-by":"crossref","first-page":"769187","DOI":"10.3389\/fendo.2021.769187","article-title":"Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk","volume":"12","author":"Morimont","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025091917040850600_bnaf016-B145","doi-asserted-by":"crossref","first-page":"101111","DOI":"10.1016\/j.yfrne.2023.101111","article-title":"Symptoms of mental disorders and oral contraception use: a systematic review and meta-analysis","volume":"72","author":"Kraft","year":"2024","journal-title":"Front Neuroendocrinol"},{"issue":"6","key":"2025091917040850600_bnaf016-B146","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ajog.2021.06.090","article-title":"Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials","volume":"225","author":"de Wit","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"2025091917040850600_bnaf016-B147","doi-asserted-by":"crossref","first-page":"e2335957","DOI":"10.1001\/jamanetworkopen.2023.35957","article-title":"Mental health symptoms in oral contraceptive users during short-term hormone withdrawal","volume":"6","author":"Noachtar","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"10","key":"2025091917040850600_bnaf016-B148","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025091917040850600_bnaf016-B149","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/humrep\/des113","article-title":"Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study","volume":"27","author":"Cinar","year":"2012","journal-title":"Hum Reprod"},{"issue":"1","key":"2025091917040850600_bnaf016-B150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijwd.2017.02.018","article-title":"A review of hormone-based therapies to treat adult acne vulgaris in women","volume":"3","author":"Trivedi","year":"2017","journal-title":"Int J Womens Dermatol"},{"issue":"4","key":"2025091917040850600_bnaf016-B151","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/gye.16.4.307.317","article-title":"Cycle characteristics after discontinuation of oral contraceptives","volume":"16","author":"Gnoth","year":"2002","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"2025091917040850600_bnaf016-B152","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.contraception.2016.05.014","article-title":"Combined hormonal contraceptive use among obese women and risk for cardiovascular events: a systematic review","volume":"94","author":"Horton","year":"2016","journal-title":"Contraception"},{"issue":"3","key":"2025091917040850600_bnaf016-B153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6503a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"2025091917040850600_bnaf016-B154","author":"Kaiser Family Foundation","year":"2019"},{"issue":"4","key":"2025091917040850600_bnaf016-B155","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jadohealth.2017.04.008","article-title":"Factors associated with contraceptive method choice and initiation in adolescents and young women","volume":"61","author":"Cohen","year":"2017","journal-title":"J Adolesc Health"},{"issue":"6","key":"2025091917040850600_bnaf016-B156","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/ph14060548","article-title":"Safety and benefits of contraceptives implants: a systematic review","volume":"14","author":"Rocca","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"2025091917040850600_bnaf016-B157","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/13625187.2016.1210122","article-title":"Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial","volume":"21","author":"Hou","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"4","key":"2025091917040850600_bnaf016-B158","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2004.06.011","article-title":"Contraceptive efficacy and safety of DMPA-SC","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"issue":"4","key":"2025091917040850600_bnaf016-B159","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0010-7824(97)00140-6","article-title":"Depot medroxyprogesterone acetate. Patterns of use and reasons for discontinuation","volume":"56","author":"Paul","year":"1997","journal-title":"Contraception"},{"issue":"8","key":"2025091917040850600_bnaf016-B160","first-page":"CD008815","article-title":"Progestin-only contraceptives: effects on weight","volume":"2016","author":"Lopez","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2025091917040850600_bnaf016-B161","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/AOG.0b013e3181c4e864","article-title":"Predictors of higher bone mineral density loss and use of depot medroxyprogesterone acetate","volume":"115","author":"Rahman","year":"2010","journal-title":"Obstetrics & Gynecology"},{"key":"2025091917040850600_bnaf016-B162","author":"Ortho-McNeil Pharmaceutical, Inc"},{"key":"2025091917040850600_bnaf016-B163","first-page":"167","article-title":"The pre-coital use of mini-dosage progestagens","volume":"6","author":"Cox","year":"1968","journal-title":"J Reprod Fertil Suppl"},{"issue":"4","key":"2025091917040850600_bnaf016-B164","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.contraception.2015.12.007","article-title":"Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake","volume":"93","author":"Duijkers","year":"2016","journal-title":"Contraception"},{"issue":"1","key":"2025091917040850600_bnaf016-B165","doi-asserted-by":"crossref","first-page":"100129","DOI":"10.1016\/j.advnut.2023.10.002","article-title":"Causes of low milk supply: the roles of oestrogens, progesterone, and related external factors","volume":"15","author":"Jin","year":"2023","journal-title":"Advances in Nutrition"},{"issue":"3","key":"2025091917040850600_bnaf016-B166","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/AOG.0b013e31820ce2db","article-title":"Risk of venous thromboembolism during the postpartum period: a systematic review","volume":"117","author":"Jackson","year":"2011","journal-title":"Obstetrics & Gynecology"},{"key":"2025091917040850600_bnaf016-B167","volume-title":"Medical Eligibility Criteria for Contraceptive Use","author":"World Health Organization","year":"2015","edition":"5th ed"},{"issue":"8","key":"2025091917040850600_bnaf016-B168","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3949\/ccjm.84a.16033","article-title":"Combined hormonal contraceptives and migraine: an update on the evidence","volume":"84","author":"Calhoun","year":"2017","journal-title":"Cleve Clin J Med"},{"key":"2025091917040850600_bnaf016-B169","doi-asserted-by":"crossref","first-page":"109925","DOI":"10.1016\/j.contraception.2022.109925","article-title":"Effectiveness and efficacy rates of progestin-only pills: a comprehensive literature review","volume":"119","author":"Zuniga","year":"2023","journal-title":"Contraception"},{"issue":"3","key":"2025091917040850600_bnaf016-B170","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000001047","article-title":"Practice bulletin no. 152: emergency contraception","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"2025091917040850600_bnaf016-B171","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejogrb.2023.10.035","article-title":"Emergency contraception\u2014a review","volume":"291","author":"Rudzinski","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"2025091917040850600_bnaf016-B172","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.contraception.2019.05.015","article-title":"Copper intrauterine device placement 6\u201314 days after unprotected sex","volume":"100","author":"Thompson","year":"2019","journal-title":"Contraception"},{"key":"2025091917040850600_bnaf016-B173","author":"World Health Organization","year":"2021  9"},{"issue":"11","key":"2025091917040850600_bnaf016-B174","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1093\/humrep\/deae215","article-title":"Prospective 1-year assessment of within-woman variability of follicular and luteal phase lengths in healthy women prescreened to have normal menstrual cycle and luteal phase lengths","volume":"39","author":"Henry","year":"2024","journal-title":"Hum Reprod"},{"issue":"2","key":"2025091917040850600_bnaf016-B175","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2017-01927","article-title":"Breast development in transwomen after 1 year of cross-sex hormone therapy: results of a prospective multicenter study","volume":"103","author":"de Blok","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2025091917040850600_bnaf016-B176","doi-asserted-by":"crossref","first-page":"1051695","DOI":"10.3389\/fendo.2023.1051695","article-title":"Pubertal induction in Turner syndrome without gonadal function: a possibility of earlier, lower-dose estrogen therapy","volume":"14","author":"Hasegawa","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2025091917040850600_bnaf016-B177","first-page":"272","article-title":"Assessing and addressing the risk of venous thromboembolism across the spectrum of gender affirming care: a review","volume":"29","author":"Arrington-Sanders","year":"2023","journal-title":"Endocr Pract"},{"issue":"4","key":"2025091917040850600_bnaf016-B178","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study","volume":"169","author":"Getahun","year":"2018","journal-title":"Ann Intern Med"},{"issue":"6","key":"2025091917040850600_bnaf016-B179","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s40618-020-01449-5","article-title":"Systematic review: puberty suppression with GnRH analogues in adolescents with gender incongruity","volume":"44","author":"Ramos","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"2025091917040850600_bnaf016-B180","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2147\/IJWH.S442357","article-title":"Oral GnRH antagonists in combination with estradiol and norethindrone acetate for pain relief associated with endometriosis: a review of evidence of a novel class of hormonal agents","volume":"16","author":"Othman","year":"2024","journal-title":"Int J Womens Health"},{"key":"2025091917040850600_bnaf016-B181","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejogrb.2018.03.057","article-title":"The action of estrogens and progestogens in the young female breast","volume":"230","author":"Zolfaroli","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"2025091917040850600_bnaf016-B182","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2006-1374","article-title":". Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group","volume":"92","author":"Bondy","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025091917040850600_bnaf016-B183","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/cen.13932","article-title":"Adolescent use of combined hormonal contraception and peak bone mineral density accrual: a meta-analysis of international prospective controlled studies","volume":"90","author":"Goshtasebi","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2025091917040850600_bnaf016-B184","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4331\/wjbc.v13.i3.66","article-title":"Progesterone in gender-affirming therapy of trans women","volume":"13","author":"Milionis","year":"2022","journal-title":"World J Biol Chem"},{"issue":"5","key":"2025091917040850600_bnaf016-B185","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/jsm.12487","article-title":"Clinical review: breast development in trans women receiving cross-sex hormones","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"issue":"7","key":"2025091917040850600_bnaf016-B186","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41443-021-00412-z","article-title":"Contraception across transgender","volume":"33","author":"Mancini","year":"2021","journal-title":"Int J Impot Res"},{"issue":"4","key":"2025091917040850600_bnaf016-B187","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.contraception.2018.06.006","article-title":"Family planning and contraception use in transgender men","volume":"98","author":"Light","year":"2018","journal-title":"Contraception"},{"issue":"3","key":"2025091917040850600_bnaf016-B188","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-0037-1603581","article-title":"Hypothalamic amenorrhea and the long-term health consequences","volume":"35","author":"Shufelt","year":"2017","journal-title":"Semin Reprod Med"},{"issue":"5","key":"2025091917040850600_bnaf016-B189","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1210\/jc.2017-00131","article-title":"Functional hypothalamic amenorrhea: an endocrine society clinical practice guideline","volume":"102","author":"Gordon","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025091917040850600_bnaf016-B190","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1210\/jcem.87.2.8195","article-title":"Long-term follow-up of functional hypothalamic amenorrhea and prognostic factors","volume":"87","author":"Falsetti","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025091917040850600_bnaf016-B191","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ejendo\/lvad082","article-title":"Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"189","author":"Forslund","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2025091917040850600_bnaf016-B192","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1210\/jc.2016-1896","article-title":"Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS","volume":"101","author":"Dokras","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025091917040850600_bnaf016-B193","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2025091917040850600_bnaf016-B194","first-page":"4179","article-title":"Resistance of gonadotropin releasing hormone drive to sex steroid-induced suppression in hyperandrogenic anovulation","volume":"82","author":"Daniels","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2025091917040850600_bnaf016-B195","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/978-1-4613-8483-0_11","volume-title":"Polycystic Ovary Syndrome","author":"Franks","year":"1996"},{"issue":"1","key":"2025091917040850600_bnaf016-B196","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1038\/s41598-022-05773-z","article-title":"A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas","volume":"12","author":"Lee","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"2025091917040850600_bnaf016-B197","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1472-6904-11-23","article-title":"The association between drospirenone and hyperkalemia: a comparative-safety study","volume":"11","author":"Bird","year":"2011","journal-title":"BMC Clin Pharmacol"},{"issue":"2","key":"2025091917040850600_bnaf016-B198","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025091917040850600_bnaf016-B199","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.contraception.2006.02.006","article-title":"Greater inhibition of the pituitary\u2014ovarian axis in oral contraceptive regimens with a shortened hormone-free interval","volume":"74","author":"Willis","year":"2006","journal-title":"Contraception"},{"issue":"1","key":"2025091917040850600_bnaf016-B200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/AOG.0b013e31820095a2","article-title":"Effectiveness of oral contraceptive pills in a large U.S. Cohort comparing progestogen and regimen","volume":"117","author":"Dinger","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2025091917040850600_bnaf016-B201","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.contraception.2013.09.007","article-title":"Comparison of pregnancy rates in users of extended and cyclic combined oral contraceptive (COC) regimens in the United States: a brief report","volume":"89","author":"Howard","year":"2014","journal-title":"Contraception"},{"issue":"2","key":"2025091917040850600_bnaf016-B202","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1210\/jc.2007-2287","article-title":"Effects of continuous versus cyclical oral contraception: a randomized controlled trial","volume":"93","author":"Legro","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025091917040850600_bnaf016-B203","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jama.2020.9482","article-title":"Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women's health initiative randomized clinical trials","volume":"324","author":"Chlebowski","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"2025091917040850600_bnaf016-B204","doi-asserted-by":"crossref","first-page":"e1004188","DOI":"10.1371\/journal.pmed.1004188","article-title":"Combined and progestagen-only hormonal contraceptives and breast cancer risk: a UK nested case-control study and meta-analysis","volume":"20","author":"Fitzpatrick","year":"2023","journal-title":"PLoS Med"},{"issue":"23","key":"2025091917040850600_bnaf016-B205","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"377","author":"M\u00f8rch","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"2025091917040850600_bnaf016-B206","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13643-016-0294-5","article-title":"Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis","volume":"5","author":"Asi","year":"2016","journal-title":"Syst Rev"},{"issue":"2","key":"2025091917040850600_bnaf016-B207","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/AOG.0000000000003072","article-title":"ACOG practice bulletin no. 206: use of hormonal contraception in women with coexisting medical conditions","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2025091917040850600_bnaf016-B208","doi-asserted-by":"crossref","first-page":"20180184","DOI":"10.1515\/jbcpp-2018-0184","article-title":"Drospirenone-containing oral contraceptives do not affect glucose regulation and circulating corticosterone","volume":"30","author":"Adeyanju","year":"2019","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"1","key":"2025091917040850600_bnaf016-B209","doi-asserted-by":"crossref","first-page":"e2143730","DOI":"10.1001\/jamanetworkopen.2021.43730","article-title":"Association of hormonal contraceptive use with adverse health outcomes: an umbrella review of meta-analyses of randomized clinical trials and cohort studies","volume":"5","author":"Brabaharan","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025091917040850600_bnaf016-B210","author":"American Academy of Family Physicians","year":"2015"},{"issue":"6","key":"2025091917040850600_bnaf016-B211","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1097\/AOG.0000000000002960","article-title":"ACOG practice bulletin no. 201: pregestational diabetes mellitus","volume":"132","author":"American College of Obstetricians Gynecologists\u2019 Committee on Practice Bulletins-Obstetrics","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"Suppl 1","key":"2025091917040850600_bnaf016-B212","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.2337\/dc23-S015","article-title":"15. Management of diabetes in pregnancy: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"4","key":"2025091917040850600_bnaf016-B213","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2337\/cd23-0008","article-title":"Unmasking barriers in the delivery of preconception counseling and contraception provision for patients with type 1 or type 2 diabetes","volume":"41","author":"Abushamat","year":"2023","journal-title":"Clin Diabetes"},{"issue":"7","key":"2025091917040850600_bnaf016-B214","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/dom.14367","article-title":"Prescribing trends and clinical characteristics of patients starting antiobesity drugs in the United States","volume":"23","author":"Suissa","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"2025091917040850600_bnaf016-B215","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/oby.21533","article-title":"Low adoption of weight loss medications: a comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT 2s","volume":"24","author":"Thomas","year":"2016","journal-title":"Obesity"},{"issue":"2","key":"2025091917040850600_bnaf016-B216","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an Endocrine Society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2025091917040850600_bnaf016-B217","doi-asserted-by":"crossref","first-page":"100018","DOI":"10.1016\/j.obpill.2022.100018","article-title":"Anti-obesity medications and investigational agents: an obesity medicine association (OMA) clinical practice statement (CPS) 2022","volume":"2","author":"Bays","year":"2022","journal-title":"Obes Pillars"},{"issue":"1","key":"2025091917040850600_bnaf016-B218","first-page":"CD003987","article-title":"Combination contraceptives: effects on weight","volume":"2014","author":"Gallo","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2025091917040850600_bnaf016-B219","doi-asserted-by":"crossref","first-page":"154919","DOI":"10.1016\/j.metabol.2021.154919","article-title":"Effect of oral contraceptives on energy balance in women: a review of current knowledge and potential cellular mechanisms","volume":"126","author":"Metz","year":"2022","journal-title":"Metabolism"},{"issue":"1","key":"2025091917040850600_bnaf016-B220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fertnstert.2016.09.027","article-title":"Combined hormonal contraception and the risk of venous thromboembolism: a guideline","volume":"107","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2017","journal-title":"Fertil Steril"},{"issue":"3","key":"2025091917040850600_bnaf016-B221","first-page":"CD010813","article-title":"Combined oral contraceptives: venous thrombosis","volume":"2014","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2025091917040850600_bnaf016-B222","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/jth.12224","article-title":"Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?","volume":"11","author":"Bird","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2025091917040850600_bnaf016-B223","doi-asserted-by":"crossref","first-page":"10.24926\/iip.v10i3.2002","DOI":"10.24926\/iip.v10i3.2002","article-title":"Benefits of levonorgestrel intrauterine device use vs. oral or transdermal progesterone for postmenopausal women using estrogen containing hormone therapy","volume":"10","author":"Clark","year":"2019","journal-title":"Innov Pharm"},{"issue":"Suppl 1","key":"2025091917040850600_bnaf016-B224","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/13697130802073425","article-title":"Estetrol review: profile and potential clinical applications","volume":"11","author":"Coelingh Bennink","year":"2008","journal-title":"Climacteric"},{"issue":"4","key":"2025091917040850600_bnaf016-B225","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/13625187.2017.1336532","article-title":"Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control","volume":"22","author":"Apter","year":"2017","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"2025091917040850600_bnaf016-B226","author":"Mayne Pharma"},{"issue":"11-12","key":"2025091917040850600_bnaf016-B227","first-page":"685","article-title":"A pilot safety and tolerability study of a nonhormonal vaginal contraceptive ring","volume":"54","author":"Del Priore","year":"2009","journal-title":"J Reprod Med"},{"key":"2025091917040850600_bnaf016-B228","author":"Dar\u00e9 Bioscience","year":"2023"},{"issue":"5","key":"2025091917040850600_bnaf016-B229","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1586\/erp.12.52","article-title":"Demand for male contraception","volume":"12","author":"Dorman","year":"2012","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"2025091917040850600_bnaf016-B230","doi-asserted-by":"crossref","first-page":"891589","DOI":"10.3389\/fendo.2022.891589","article-title":"Hormonal male contraception: getting to market","volume":"13","author":"Page","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025091917040850600_bnaf016-B231","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pharmthera.2015.11.004","article-title":"Non-hormonal male contraception: a review and development of an Eppin based contraceptive","volume":"157","author":"O'Rand","year":"2016","journal-title":"Pharmacol Ther"},{"issue":"1","key":"2025091917040850600_bnaf016-B232","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ucl.2013.08.012","article-title":"Male contraception: history and development","volume":"41","author":"Kogan","year":"2014","journal-title":"Urol Clin North Am"},{"issue":"9","key":"2025091917040850600_bnaf016-B233","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/jwh.2021.0394","article-title":"Acceptability of a long-acting, multipurpose vaginal ring: findings from a phase I trial in the U.S. and Dominican Republic","volume":"31","author":"Tolley","year":"2022","journal-title":"J Womens Health (Larchmt)"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/edrv\/advance-article-pdf\/doi\/10.1210\/endrev\/bnaf016\/63496893\/bnaf016.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/46\/5\/736\/63496893\/bnaf016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/46\/5\/736\/63496893\/bnaf016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T21:04:38Z","timestamp":1758315878000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/46\/5\/736\/8163516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":233,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,6,16]]},"published-print":{"date-parts":[[2025,9,16]]}},"URL":"https:\/\/doi.org\/10.1210\/endrev\/bnaf016","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,6,16]]}}}